Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Drug Resistance, Neoplasm drug effects"" wg kryterium: Temat


Tytuł :
MET Signaling Overcomes Epidermal Growth Factor Receptor Inhibition in Normal and Colorectal Cancer Stem Cells Causing Drug Resistance
Index Terms :
Antineoplastic Agents/pharmacology
Cell Line, Tumor
Cell Proliferation/drug effects
Colorectal Neoplasms/drug therapy
Drug Resistance, Neoplasm/drug effects
ErbB Receptors/antagonists & inhibitors
Gefitinib/pharmacology
Genes, APC
Humans
Intestinal Mucosa/drug effects
Mutation
Neoplastic Stem Cells/drug effects
Protein Kinase Inhibitors/pharmacology
Proto-Oncogene Proteins c-met/antagonists & inhibitors
Pyrazines/pharmacology
Signal Transduction
Triazines/pharmacology
Article
Źródło :
Gastroenterology vol.157 (2019) nr.4 p.1153-1155.e1 [ISSN 0016-5085]
URL :
https://pure.knaw.nl/portal/en/publications/met-signaling-overcomes-epidermal-growth-factor-receptor-inhibition-in-normal-and-colorectal-cancer-stem-cells-causing-drug-resistance(09dac440-1221-4d76-826c-d3f17ce4e1b4).html">https://pure.knaw.nl/portal/en/publications/met-signaling-overcomes-epidermal-growth-factor-receptor-inhibition-in-normal-and-colorectal-cancer-stem-cells-causing-drug-resistance(09dac440-1221-4d76-826c-d3f17ce4e1b4).html
Zasób elektroniczny
Tytuł :
MET Signaling Overcomes Epidermal Growth Factor Receptor Inhibition in Normal and Colorectal Cancer Stem Cells Causing Drug Resistance
Index Terms :
Antineoplastic Agents/pharmacology
Cell Line, Tumor
Cell Proliferation/drug effects
Colorectal Neoplasms/drug therapy
Drug Resistance, Neoplasm/drug effects
ErbB Receptors/antagonists & inhibitors
Gefitinib/pharmacology
Genes, APC
Humans
Intestinal Mucosa/drug effects
Mutation
Neoplastic Stem Cells/drug effects
Protein Kinase Inhibitors/pharmacology
Proto-Oncogene Proteins c-met/antagonists & inhibitors
Pyrazines/pharmacology
Signal Transduction
Triazines/pharmacology
Article
Źródło :
Gastroenterology vol.157 (2019) nr.4 p.1153-1155.e1 [ISSN 0016-5085]
URL :
https://pure.knaw.nl/portal/en/publications/met-signaling-overcomes-epidermal-growth-factor-receptor-inhibition-in-normal-and-colorectal-cancer-stem-cells-causing-drug-resistance(09dac440-1221-4d76-826c-d3f17ce4e1b4).html">https://pure.knaw.nl/portal/en/publications/met-signaling-overcomes-epidermal-growth-factor-receptor-inhibition-in-normal-and-colorectal-cancer-stem-cells-causing-drug-resistance(09dac440-1221-4d76-826c-d3f17ce4e1b4).html
Zasób elektroniczny
Tytuł :
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
Index Terms :
Androgen deprivation therapy
Androgen receptor
Biomarkers
Docetaxel
Enzalutamide
MCRPC
Mutations
Prostate cancer
Treatment resistance
androgen deprivation therapy
biomarkers
mCRPC
prostate cancer
androgen receptor
mutations
docetaxel
enzalutamide
treatment resistance
Humans
Drug Resistance, Neoplasm/drug effects
Male
Phenylthiohydantoin/analogs & derivatives
Prostatic Neoplasms, Castration-Resistant/drug therapy
Endocrinology
Oncology
Cancer Research
Endocrinology, Diabetes and Metabolism
Research Support, Non-U.S. Gov't
Journal Article
Tijdschriftartikel
Article
Źródło :
Endocrine-related cancer vol.26 (2019) nr.1 p.R31-R52 [ISSN 1351-0088]
URL :
https://research.tue.nl/en/publications/enzalutamide-therapy-for-advanced-prostate-cancer(e684cbca-aa8a-4687-a92c-cecbb6d86f63).html">https://research.tue.nl/en/publications/enzalutamide-therapy-for-advanced-prostate-cancer(e684cbca-aa8a-4687-a92c-cecbb6d86f63).html
https://pure.tue.nl/ws/files/111513632/_14796821_Endocrine_Related_Cancer_Enzalutamide_therapy_for_advanced_prostate_cancer_efficacy_resistance_and_beyond.pdf">https://pure.tue.nl/ws/files/111513632/_14796821_Endocrine_Related_Cancer_Enzalutamide_therapy_for_advanced_prostate_cancer_efficacy_resistance_and_beyond.pdf
Zasób elektroniczny
Tytuł :
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.
Index Terms :
Sciences bio-médicales et agricoles
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Boronic Acids -- administration & dosage
Dexamethasone -- administration & dosage -- adverse effects
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm -- drug effects
France
Humans
Medical Oncology -- organization & administration
Middle Aged
Multiple Myeloma -- drug therapy
Pyrazines -- administration & dosage
Societies, Medical
Thalidomide -- administration & dosage -- adverse effects -- analogs & derivatives
Treatment Failure
Treatment Outcome
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/200242">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/200242
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Index Terms :
Cancérologie
Adult
Aged
Antineoplastic Agents -- therapeutic use
Boronic Acids -- therapeutic use
Cohort Studies
Drug Resistance, Neoplasm -- drug effects
Female
Follow-Up Studies
Humans
Lymphoma, Follicular -- drug therapy -- mortality -- pathology
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Grading
Neoplasm Recurrence, Local -- drug therapy -- mortality -- pathology
Prognosis
Pyrazines -- therapeutic use
Salvage Therapy
Survival Rate
Bortezomib
Clinical trial
Follicular lymphoma
Phase II
Salvage therapy
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168066">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168066
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours.
Index Terms :
Cancérologie
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects -- pharmacokinetics -- therapeutic use
Benzenesulfonates -- administration & dosage -- adverse effects -- pharmacokinetics
Cohort Studies
Disease Progression
Drug Administration Schedule
Drug Resistance, Neoplasm -- drug effects
Female
Humans
Male
Middle Aged
Neoplasms -- drug therapy -- pathology
Pyridines -- administration & dosage -- adverse effects -- pharmacokinetics
Taxoids -- administration & dosage -- adverse effects -- pharmacokinetics
Treatment Outcome
Combination
Docetaxel
Phase I
Solid tumours
Sorafenib
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144356">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144356
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.
Index Terms :
Cancérologie
Androgens -- therapeutic use
Animals
Apoptosis -- radiation effects
Benzazepines -- therapeutic use
Caspase 3 -- analysis
Cell Cycle
Cell Line, Tumor
Cell Survival -- drug effects -- radiation effects
DNA Breaks, Double-Stranded
Drug Resistance, Neoplasm -- drug effects
Histones -- analysis
Humans
Immunoblotting -- methods
Ki-67 Antigen -- analysis
Male
Mice
Mice, Nude
Nocodazole -- therapeutic use
Prostatic Neoplasms -- drug therapy -- pathology -- radiotherapy
Protein-Serine-Threonine Kinases -- antagonists & inhibitors
Radiation Tolerance -- drug effects
Radiation-Sensitizing Agents -- therapeutic use
Aurora kinase A
MLN8054
Prostate cancer
Radiation
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/125887">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/125887
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
Index Terms :
Sciences bio-médicales et agricoles
Amaryllidaceae Alkaloids -- chemistry
Amaryllidaceae Alkaloids -- isolation & purification
Amaryllidaceae Alkaloids -- pharmacology
Antineoplastic Agents, Phytogenic -- chemistry
Antineoplastic Agents, Phytogenic -- isolation & purification
Antineoplastic Agents, Phytogenic -- pharmacology
Apoptosis -- drug effects
Drug Resistance, Neoplasm -- drug effects
Drug Screening Assays, Antitumor
Humans
Molecular Structure
Phenanthridines -- chemistry
Phenanthridines -- isolation & purification
Phenanthridines -- pharmacology
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/68166">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/68166
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies